Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Darbesa 40mcg Injection

Prescription Icon
Prescription Required

Marketer

Balint pharmaceuticals

Salt Composition

Darbepoetin alfa (40mcg)

Overview Darbesa 40mcg Injection

Epoetin alfa 40mcg injection treats anemia resulting from chronic kidney disease or chemotherapy. Its mechanism involves bone marrow stimulation to increase red blood cell production. This medication requires careful administration due to potential serious adverse reactions; expert medical supervision is crucial. Strict adherence to physician instructions is mandatory. Administration occurs under healthcare professional oversight. Frequent side effects may include abdominal discomfort, hypertension, skin rash, injection site pain, dyspnea, cough, and peripheral swelling. Report severe headache, visual disturbances, nausea, vomiting, or convulsions, indicative of dangerously high blood pressure. Regular blood tests will monitor electrolyte (e.g., potassium) levels, hemoglobin, and blood cell counts. Discontinue use and seek medical advice immediately upon experiencing shortness of breath or a skin eruption. Prior to commencing treatment, disclose any history of heart disease, hypertension, seizures, or strokes. Pregnant, breastfeeding, or intending to become pregnant or breastfeed individuals should consult their physician regarding safety.

Primary Ingredients of Darbesa 40mcg Injection

There is no text provided to rephrase.

Uses of Darbesa 40mcg Injection

Managing Anemia in Chronic Kidney Disease Patients | Addressing Chemotherapy-Induced Anemia

Major Benefits of Darbesa 40mcg Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

Common Side effects of Darbesa 40mcg Injection:

  • Abdominal pain
  • High blood pressure
  • Rash
  • Injection site pain
  • Breathlessness
  • Cough
  • Peripheral edema
  • Procedural hypotension (low blood pressure)
  • Convulsion
  • Thromboembolism

How to use Darbesa 40mcg Injection:

Administering this medication will be handled by your physician or registered nurse; self-medication is strictly prohibited.

How Darbesa 40mcg Injection works:

Darbepoetin alfa 40 mcg injection is a medication that boosts red blood cell production. This erythropoiesis-stimulating agent (ESA) acts by prompting increased red blood cell synthesis within the bone marrow.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption with Darbesa 40mcg Injection may pose safety risks; seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Administering Darbesa 40mcg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Administration of Darbesa 40mcg Injection while breastfeeding is likely inadvisable. Preliminary research in humans indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingSAFE

The administration of Darbesa 40mcg Injection typically does not impair driving ability.

KidneyKidneySAFE IF PRESCRIBED

Darbesa 40mcg Injection poses no safety concerns for individuals with kidney impairment; no dosage modification is necessary.

LiverLiverCAUTION

Caution is advised when administering Darbesa 40mcg Injection to individuals with hepatic impairment. Dosage modification of Darbesa 40mcg Injection might be necessary. Physician consultation is recommended.

What if you forget to take Darbesa 40mcg Injection :

Should you forget a Darbesa 40mcg Injection, administer it promptly. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Darbesa 40mcg Injection

LabelValue
Chemical Category Amino Acid and Peptide Analogs
Developing Habits No.
Treatment Category KINSHIP
Action Category Erythropoietin-stimulating drug

FAQs on Darbesa 40mcg Injection

Within 2 to 6 weeks of beginning Darbesa 40mcg injections, you should see a rise in your red blood cell count (hemoglobin levels). Consult your doctor with any other questions.
Darbesa 40mcg Injection carries significant risks, including potentially fatal side effects, demanding careful administration by a physician experienced with this therapy. Strict adherence to prescribed instructions is crucial.
Darbesa 40mcg Injection may be ineffective if you have iron, folic acid, or vitamin B12 deficiencies; address these before treatment. Other factors hindering response include bleeding, infections, inflammation, and bone marrow fibrosis. Consult your doctor for further guidance.
Darbesa 40mcg Injection treats anemia related to chronic kidney disease in children over one year old. Its effectiveness and side effects in children are comparable to those in adults. Consult your physician if you have any concerns.
Darbesa 40mcg Injection can influence blood pressure. Monitor blood pressure closely, especially during initial treatment. Patients with hypertension should manage their blood pressure appropriately. Discontinuation of Darbesa 40mcg Injection may be necessary if blood pressure remains uncontrolled.
Darbesa 40mcg Injection should only be used under a doctor's prescription. Its use is contraindicated in patients with uncontrolled hypertension, a history of pure red cell aplasia (PRCA) triggered by Darbesa 40mcg Injection or similar medications, or a history of serious allergic reactions to this drug.
Darbesa 40mcg Injection
2,159
MRP 2,499
13% off